Matters of legal in nature including licensing, intellectual property, and lawsuits.
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit against BGI Group’s subsidiary, Latvia MGI Tech SIA, in the Düsseldorf Regional Court in Germany. The complaint alleges that BGI’s sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents, infringe EP 1 530 578 B1. This patent covers... Read more
– Expanded FluoroType™ MTBDR 2.0 Liquid Array molecular assay with CE-IVD mark provides highly differentiated tuberculosis (TB) detection and antibiotic resistance testing – Novel FluoroCycler™ XT PCR system with CE-IVD mark enables new Liquid Array format NEHREN, Germany, March 22, 2019 /PRNewswire/ — In time for the World Tuberculosis (TB) Day 2019 on Sunday, March... Read more
March 19, 2019 – Pittcon 2019 – Philadelphia, PA JEOL USA has expanded its mass spectrometer product line with the development of a new GC-triple quadrupole mass spectrometer system introduced at the Pittcon Conference in Philadelphia this week in booth #3035. The new JMS-TQ4000GC answers the need for an ultrahigh-speed triple-quadrupole mass spectrometer that accurately... Read more
Basel, 11 March 2019 FDA grants Roche’s Tecentriq in combination with Abraxane accelerated approval for people with PD-L1-positive, metastatic triple-negative breast cancer This Tecentriq combination is the first cancer immunotherapy regimen approved for breast cancer Triple-negative breast cancer is an aggressive disease, with high unmet medical need Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced... Read more
Agilent and Imperial College London Strengthen Partnership Agilent Measurement Suite at Imperial to boost research in molecular sciences SANTA CLARA, Calif., March 6, 2019 Agilent Technologies Inc. (NYSE: A) and Imperial College London have announced that, as part of its ongoing collaboration, several state-of-the-art analytical instruments have been installed into the college’s Molecular Sciences Research... Read more
M ST. LOUIS, March 5, 2019 /PRNewswire/ — Canopy Biosciences™ LLC, a leading provider of gene editing and gene expression products and services, announced today that they had exclusively licensed technology for error correction in next generation sequencing (NGS) from Washington University. This license includes both a novel method and bioinformatic tools that combine to significantly improve... Read more
04 MAR 2019 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA Patent covers paired Cas9 nickase technology to advance gene therapy and research, reduce off-target effects Marks MilliporeSigma’s 13th CRISPR patent overall Actively licensing CRISPR-related patents to interested parties Burlington, Massachusetts, March 4, 2019 – MilliporeSigma, a leader in genome editing, today announced that the Canadian Patent Office has allowed... Read more
RYE BROOK, N.Y.–(BUSINESS WIRE)–Feb. 22, 2019– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Senior Vice President and Chief Financial Officer, Mark Rajkowski, will participate in a panel discussion entitled Fast Movers in Smart Water and Xylem’s VP and General... Read more
News Release February 19, 2019 Your Contact:Media Relationskaren.tiano@emdmillipore.comPhone: +1 978 495 0093 Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions of the genome, increasing genome coverage Burlington, Massachusetts, February 19, 2019 — MilliporeSigma, a leader in genome editing, today announced that the United States Patent and... Read more
19 FEB 2019 | DARMSTADT, GERMANY Proxy-CRISPR technology provides solution to improve genome editing and advance new possibilities for research Helps modify difficult-to-access regions of the genome, increasing genome coverage Merck KGaA, Darmstadt, Germany, a leading science and technology company and leader in genome editing, today announced that the United States Patent and Trademark Office has issued... Read more